Literature DB >> 3380215

Intact humoral immune response in patients on continuous ambulatory peritoneal dialysis.

D J Versluis1, W E Beyer, N Masurel, P P Diderich, P Kramer, W Weimar.   

Abstract

After influenza vaccination no statistically significant difference in antibody response was observed between patients on continuous ambulatory peritoneal dialysis (CAPD) and healthy volunteers while a large group of hemodialysis (HD) patients was found to have a significantly lower response rate. This difference remained statistically significant when CAPD patients were compared to a matched HD group. As the antibody formation after influenza vaccination is a T cell-dependent phenomenon, the normal immune response to vaccination suggests an intact humoral and cellular immunity in CAPD patients.

Entities:  

Mesh:

Year:  1988        PMID: 3380215     DOI: 10.1159/000184979

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  6 in total

Review 1.  Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses.

Authors:  Ken M Kunisaki; Edward N Janoff
Journal:  Lancet Infect Dis       Date:  2009-08       Impact factor: 25.071

2.  Immunogenicity of low-dose MF59-adjuvanted 2009 influenza A/H1N1 vaccine in dialysis patients.

Authors:  Jungmin Son; Soo Bong Lee; Dong Won Lee; Il Young Kim; Su Jin Lee; Sun Min Lee; Sang Heon Song; Eun Young Seong; Ihm Soo Kwak
Journal:  Clin Exp Nephrol       Date:  2012-09-19       Impact factor: 2.801

Review 3.  The use of vaccines in renal failure.

Authors:  D W Johnson; S J Fleming
Journal:  Clin Pharmacokinet       Date:  1992-06       Impact factor: 6.447

Review 4.  Humoral immune response to influenza vaccination in patients from high risk groups.

Authors:  L B Brydak; M Machala
Journal:  Drugs       Date:  2000-07       Impact factor: 9.546

5.  Immune response to influenza vaccination in children with renal disease.

Authors:  S L Furth; A M Neu; S A McColley; B Case; M Steinhoff; B Fivush
Journal:  Pediatr Nephrol       Date:  1995-10       Impact factor: 3.714

6.  Split inactivated COBRA vaccine elicits protective antibodies against H1N1 and H3N2 influenza viruses.

Authors:  James D Allen; Satyajit Ray; Ted M Ross
Journal:  PLoS One       Date:  2018-09-28       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.